ARCHIVES

Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says

This article is from The Cancer Letter archive.

Vol. 16 No. 16 | April 20, 1990

Download PDF Visit The Full Archive

Related Articles

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

NIH appoints panel to review conflict of interest rules.

February 27, 2004

Advisors seek support for NCI’s “special authorities” granted in 1971.

July 15, 2005

AACR Says 5 Percent Of Meeting Registrants Couldn’t Attend Due To Volcanic Ash In Europe

April 30, 2010

Duke Insiders Allege Intimidation By Administration

July 23, 2010

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014